451O Preliminary evidence of clinical activity from phase I and Ib trials of the CLK/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors
| Autor: | Scott, A., Call, J.A., Chandana, S., Borazanci, E., Falchook, G.S., Bordoni, R., Richey, S., Starodub, A., Chung, V., Lakhani, N.J., Lam, E., Schaffer, K., Wang, J.S., Shapiro, G., Sachdev, J.C., Beaupre, D., Tolcher, A.W. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S742-S743 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|